Author:
Tzellos Thrasivoulos,Kyrgidis Athanassios,Vakirlis Efstratios,Trigoni Anastasia
Reference5 articles.
1. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial;Baeten;Lancet,2013
2. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study;Papp;Br J Dermatol,2013
3. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis;Papp;N Engl J Med,2012
4. Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production;von Vietinghoff;Kidney Int,2010
5. Better reporting of harms in randomized trials: an extension of the CONSORT statement;Ioannidis;Ann Intern Med,2004
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献